Elan Corporation

6099.T
Medical Care Facilities
2026/10/30 12:01 Updated
Market Cap: $281.8M (¥44.5B)
Stock Price: $4.66 (¥736)
Exchange Rate: 1 USD = ¥157.98

Elan Corporation Financial Summary for the Third Quarter of the Fiscal Year Ending December 2026 (Japanese GAAP) (Consolidated)

For the nine months ended the third quarter of the fiscal year ending December 2026, net sales were 45,033 million yen (Year-over-Year +10.5%), operating income was 3,967 million yen (+31.2%), ordinary income was 4,195 million yen (+39.5%), and net income attributable to owners of parent for the quarter was 2,752 million yen (+36.0%). The number of facilities adopting the CS set increased to 2,972. Full-year forecasts were unchanged and dividend guidance remains as previously indicated (16 yen per distribution as of the end of the second quarter). Financial position is healthy with total assets of 28,554 million yen, net assets of 16,751 million yen, and a shareholders' equity ratio of 57.2%.

Importance:
Page Updated: October 30, 2026
IR Disclosure Date: October 30, 2026

Key Figures

  • Net Sales: 45,033,264 thousand yen (Year-over-Year +10.5%)
  • Operating Income: 3,967,012 thousand yen (Year-over-Year +31.2%)
  • Net Income Attributable to Owners of Parent (Quarter): 2,751,664 thousand yen (Year-over-Year +36.0%)

AI要約

Overview of Results

Elan Corporation recorded net sales of 45,033 million yen, operating income of 3,967 million yen, ordinary income of 4,195 million yen, and net income attributable to owners of parent for the quarter of 2,752 million yen for the nine months ended the third quarter of the fiscal year ending December 2026, representing significant increases year-over-year. New contracts totaled 244 facilities and cancellations were 102 facilities, bringing the number of facilities with CS set installations to 2,972. Expansion of the nursing-care and medical-related business addressing an aging society progressed steadily.

Financial Position and Outlook

Total assets stood at 28,554 million yen, net assets at 16,751 million yen, and the shareholders' equity ratio was 57.2%, maintaining financial soundness. There were no revisions to the full-year performance forecasts, and no particular changes were indicated to dividend forecasts. Given the potential for full-year growth and expansion in the nursing-care and medical market, stable growth is expected. An earnings briefing will be held for institutional investors and analysts.

Net Sales Trend

Operating Income Trend

Net Income Attributable to Owners of Parent (Quarter) Trend

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Elan Corporation

Company overview · Stock price · Financial data · All IR

View company page →